# GK Healthcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gk-healthcare

- Industry: Software
- Headquarters: Suzhou, China
- Website: www.gkkc-health.com
- Latest round: Series A (Feb 21, 2025)
- Investors on record: 2

## About

Established in 2015 and based in Suzhou, China, GK Healthcare operates as a medical imaging intelligent diagnosis and treatment solutions provider that provides intelligent medical health management services platform and image processing services. It acquired the Class II certificate in 2022 and the Class III certificate in 2023. In February 2025, it closed a series A funding led by new investor First Capital, with participation from other new investor SND Ventures Group. 

GK Healthcare has developed an AI smart medical health management system. The company currently has eight product lines, including Kangcheng Ruishu, Kangcheng Ruiying, Kangcheng Ruinao M, etc. The main products are Kangcheng Ruishu (a scientific research big data management platform) and Kangcheng Ruiying (an AI diagnosis and treatment modeling and analysis system). The systems and products are used in imaging diagnosis, surgical planning, navigation, and postoperative control and management.

The company generates revenue by providing intelligent medical image processing software and systems.

The company will optimize existing technologies, improve the accuracy of diagnosis and treatment of various tumors and brain diseases and expand the application of brain science in rehabilitation therapy, mental health and other fields. It will use the funds to promote product research and development and market expansion.

## Funding rounds

- Series A, Feb 21, 2025 — SND Ventures Group, First Capital

## Investors

- SND Ventures Group (https://capitalatlas.ai/funds/snd-ventures-group) — Series A
- First Capital (https://capitalatlas.ai/funds/first-capital) — Series A
